Outcomes13

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

1 to 13 of 13

Type	Outcome	Time frame	Population	Units	Measured as
PRIMARY	The Proportion of CAT Score Responders in the Full Analysis Set at Week 12	12 Weeks	The full analysis set (FAS) included all subjects administered the study medication at visit 2 (day 1), and had a CAT completed at baseline and from at least one post-treatment visit.	Participants	COUNT_OF_PARTICIPANTS
SECONDARY	The Proportion of CAT Score Responders in the Full Analysis Set at Week 6	6 Weeks	The full analysis set (FAS) included all subjects administered the study medication at visit 2 (day 1), and had a CAT completed at baseline and from at least one post-treatment visit.	Participants	COUNT_OF_PARTICIPANTS
SECONDARY	Mean Change From Baseline - CAT Score in the Full Analysis Set	At week 6 and week 12	The full analysis set (FAS) included all subjects administered the study medication at visit 2 (day 1), and had a CAT completed at baseline and from at least one post-treatment visit.	units on a scale	LEAST_SQUARES_MEAN
SECONDARY	Mean Change From Baseline - CAT Individual Item (1, Cough) in the Full Analysis Set	At week 6 and week 12	The full analysis set (FAS) included all subjects administered the study medication at visit 2 (day 1), and had a CAT completed at baseline and from at least one post-treatment visit.	units on a scale	LEAST_SQUARES_MEAN
SECONDARY	Mean Change From Baseline - CAT Individual Item (2, Mucus) in the Full Analysis Set	At week 6 and week 12	The full analysis set (FAS) included all subjects administered the study medication at visit 2 (day 1), and had a CAT completed at baseline and from at least one post-treatment visit.	units on a scale	LEAST_SQUARES_MEAN
OTHER_PRE_SPECIFIED	Mean Change From Baseline in Blood Pressure in the Safety Analysis Set	12 Weeks	The safety analysis set (SAS) included all subjects who were administered the study medication at day 1 (n=20). However, 2 subjects did not complete week 6 and week 12 visits and did not have a change from baseline calculated.	mmHg	MEAN
OTHER_PRE_SPECIFIED	Mean Change From Baseline in Pulse Rate in the Safety Analysis Set	12 Weeks	The safety analysis set (SAS) included all subjects who were administered the study medication at day 1 (n=20). However, 2 subjects did not complete week 6 and week 12 visits and did not have a change from baseline calculated.	bpm	MEAN
SECONDARY	Mean Change From Baseline - CAT Individual Item (3, Chest Tight) in the Full Analysis Set	At week 6 and week 12	The full analysis set (FAS) included all subjects administered the study medication at visit 2 (day 1), and had a CAT completed at baseline and from at least one post-treatment visit.	units on a scale	LEAST_SQUARES_MEAN
SECONDARY	Mean Change From Baseline - CAT Individual Item (4, Breathless) in the Full Analysis Set	At week 6 and week 12	The full analysis set (FAS) included all subjects administered the study medication at visit 2 (day 1), and had a CAT completed at baseline and from at least one post-treatment visit.	units on a scale	LEAST_SQUARES_MEAN
SECONDARY	Mean Change From Baseline - CAT Individual Item (5, Activities) in the Full Analysis Set	At week 6 and week 12	The full analysis set (FAS) included all subjects administered the study medication at visit 2 (day 1), and had a CAT completed at baseline and from at least one post-treatment visit.	units on a scale	LEAST_SQUARES_MEAN
SECONDARY	Mean Change From Baseline - CAT Individual Item (6, Confidence) in the Full Analysis Set	At week 6 and week 12	The full analysis set (FAS) included all subjects administered the study medication at visit 2 (day 1), and had a CAT completed at baseline and from at least one post-treatment visit.	units on a scale	LEAST_SQUARES_MEAN
SECONDARY	Mean Change From Baseline - CAT Individual Item (7, Sleep) in the Full Analysis Set	At week 6 and week 12	The full analysis set (FAS) included all subjects administered the study medication at visit 2 (day 1), and had a CAT completed at baseline and from at least one post-treatment visit.	units on a scale	LEAST_SQUARES_MEAN
SECONDARY	Mean Change From Baseline - CAT Individual Item (8, Energy) in the Full Analysis Set	At week 6 and week 12	The full analysis set (FAS) included all subjects administered the study medication at visit 2 (day 1), and had a CAT completed at baseline and from at least one post-treatment visit.	units on a scale	LEAST_SQUARES_MEAN

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT06460493/outcomes

API reference For AI assistants